1. Home
  2. MIRA vs CISS Comparison

MIRA vs CISS Comparison

Compare MIRA & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • CISS
  • Stock Information
  • Founded
  • MIRA 2020
  • CISS 2022
  • Country
  • MIRA United States
  • CISS Greece
  • Employees
  • MIRA N/A
  • CISS N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • CISS Marine Transportation
  • Sector
  • MIRA Health Care
  • CISS Consumer Discretionary
  • Exchange
  • MIRA Nasdaq
  • CISS Nasdaq
  • Market Cap
  • MIRA 10.2M
  • CISS 8.6M
  • IPO Year
  • MIRA 2023
  • CISS N/A
  • Fundamental
  • Price
  • MIRA $2.36
  • CISS $1.30
  • Analyst Decision
  • MIRA
  • CISS
  • Analyst Count
  • MIRA 0
  • CISS 0
  • Target Price
  • MIRA N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • MIRA 11.4M
  • CISS 284.9K
  • Earning Date
  • MIRA 09-13-2024
  • CISS 08-30-2024
  • Dividend Yield
  • MIRA N/A
  • CISS N/A
  • EPS Growth
  • MIRA N/A
  • CISS N/A
  • EPS
  • MIRA N/A
  • CISS 48.19
  • Revenue
  • MIRA N/A
  • CISS $38,379,148.00
  • Revenue This Year
  • MIRA N/A
  • CISS N/A
  • Revenue Next Year
  • MIRA N/A
  • CISS N/A
  • P/E Ratio
  • MIRA N/A
  • CISS $0.03
  • Revenue Growth
  • MIRA N/A
  • CISS N/A
  • 52 Week Low
  • MIRA $0.51
  • CISS $1.11
  • 52 Week High
  • MIRA $6.95
  • CISS $77.00
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 59.37
  • CISS 39.53
  • Support Level
  • MIRA $0.62
  • CISS $1.35
  • Resistance Level
  • MIRA $5.01
  • CISS $1.55
  • Average True Range (ATR)
  • MIRA 0.57
  • CISS 0.08
  • MACD
  • MIRA 0.26
  • CISS 0.01
  • Stochastic Oscillator
  • MIRA 41.07
  • CISS 16.67

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: